Меню
Идёт набор NCT05491005

The eHealth Diabetes Remission Trial

Без фазы С лечением Diabetes Mellitus, Type 2

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Total diet replacement, eHealth, Face-to-face.
Кому может быть актуально
Состояния в реестре: Diabetes Mellitus, Type 2. Базовые параметры: 20 лет — 70 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Швеция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

eHealth Diabetes Remission Trial (Swedish: Remission av Typ 2 Diabetes Med hjälp av eHälsa

Обзор

Overweight patients with type 2 diabetes are offered a total diet replacement with the goal of weight loss and diabetes remission. Study participants are randomised to eHealth follow-up or face-to-face follow-up, but the dietary advice is the same in both groups. A healthy control group with normal glucose tolerance is examined once but is not randomised and does not receive any intervention.

Подробное описание

One hundred and six overweight patients with type 2 diabetes replace usual foods with total diet replacement (850 kcal/day) for 3 months with the goal of 15 kg weight loss and diabetes remission (HbA1c \< 48 mmol/mol without diabetes medication). After 3 months of total diet replacement, food is reintroduced stepwise, and an individually tailored energy prescription is used to prevent weight regain. If study participants do not reach the weight loss goal at 3 months, they are recommended two additional months of total diet replacement. If weight regain occurs during the weight maintenance phase, a rescue plan with total diet replacement will be recommended. To increase the chances to maintain their lower body weight, participants will use a program specifically design for that purpose based on cognitive behavioural therapy. Total study duration is two years.

The one hundred and six participants are randomised to either the eHealth follow-up or the face-to-face follow-up. The dietary advice to achieve and maintain weight loss is the same in both groups and delivered by the same dietician, physician, and nurse but the method of follow-up differs between groups (eHealth vs face-to-face).

eHealth group:

All study information and the cognitive behavioural therapy program is given by an eHealth application in Stöd och behandling which is part of 1177.se. Participants register body weight, fasting blood glucose, and blood pressure every morning at 1177.se. Regularly a measurement of HbA1c is taken at home. Participants will have scheduled video appointments with the study dietician, study nurse or study physician.

Face-to-face group:

Participants have appointments in the medical office with the study physician/nurse/dietician. At the appointments, body weight, blood pressure and capillary blood glucose is measured. HbA1c is measured during the appointments at 0, 6, 12 and 24 months. The cognitive behavioral therapy program for the control group is identical to the program of the intervention group, but the program is delivered during the face-to-face appointments.

Healthy control group:

Fifteen healthy participants with normal glucose tolerance, stable body weight for at least one year and matched to the study participants for sex, age, and weight after one year study duration, will be examined once. These participants are not randomised and do not receive any intervention.

Outcomes:

Primary and secondary outcome measures are compared between 1) the experimental eHealth group and 2) the experimental face-to-face group. For the other pre-specified outcome measures the experimental eHealth group and the experimental face-to-face group are taken together as one group, examined twice (baseline and 12 months) and compared to the healthy control group, that is examined only once.

Long-term follow-up:

Because long term data on diabetes remission by total diet replacement are lacking, study participants will be followed after they have finished the study. Data of the national diabetes registry from participants of this study will be compared to other patients in the national diabetes registry not participating in this study but matched for age, sex and diabetes duration to the study participants.

Вмешательства

  • Поведенческое Total diet replacement
    Total diet replacement (850 kcal/day) for 3 months followed by weight maintenance for 21 months.
  • Поведенческое eHealth
    All follow-up through an eHealth application and video meetings.
  • Поведенческое Face-to-face
    All follow-up through face-to-face meetings.

Первичные конечные точки

  • HbA1c [Срок оценки: 12 months]
Вторичные конечные точки (12)
  • HbA1c [Срок оценки: 6 and 24 months]
  • Diabetes remission [Срок оценки: 6, 12 and 24 months]
  • Body weight [Срок оценки: 6, 12 and 24 months]
  • Achieved weight loss of at least 15 kg [Срок оценки: 6, 12 and 24 months]
  • Incremental costs per diabetes remission [Срок оценки: 24 months]
  • Estimated lifetime costs [Срок оценки: 24 months]
  • Estimated lifetime costs per quality-adjusted life-year (QALY) [Срок оценки: 24 months]
  • Fasting blood glucose [Срок оценки: 6, 12, 24 months]
  • P-glucose 120 minutes after the oral glucose tolerance test [Срок оценки: 6, 12, 24 months]
  • Number of prescribed oral anti diabetic medications [Срок оценки: 6, 12, 24 months]
  • Number of prescribed antihypertensive medications [Срок оценки: 6, 12, 24 months]
  • Blood pressure (systolic/diastolic) [Срок оценки: 6, 12, 24 months]

Критерии участия

Критерии включения

  • Type 2 diabetes with duration 0-6 years
  • BMI 27 kg/m2 and higher
  • HbA1c 43 mmol/mol or higher (48 or higher if without diabetes medication)

Критерии исключения

  • Insulin treatment
  • Weight loss more than 5 kg during the past 6 months
  • Diagnosed eating disorder
  • eGFR < 30 ml/min/1,73m2
  • Myocardial infarction last six months
  • Severe heart failure (NYHA class III)
  • Ongoing cancer
  • Pregnancy
  • Treatment with antipsychotic drugs

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

Швеция · 3 центра
  • Bra Liv Råslätt vårdcentral — Jönköping
  • Örnsköldsvik hospital — Örnsköldsvik
  • Department of Public Health and Clinical Medicine, Medicine — Umeå

Публикации

  • Tsapas A, Avgerinos I, Karagiannis T, Malandris K, Manolopoulos A, Andreadis P, Liakos A, Matthews DR, Bekiari E. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Ann Intern Med. 2020 Aug 18;173(4):278-286. doi: 10.7326/M20-0864. Epub 2020 Jun 30. PMID 32598218
  • Gladzki L, Brunstrom M, Otten J. Reduced antihypertensive treatment with maintained ambulatory blood pressure control following weight loss in type 2 diabetes. Blood Press. 2026 Dec;35(1):2676362. doi: 10.1080/08037051.2026.2676362. Epub 2026 Jun 5. PMID 42154590
  • Otten J, Tellstrom A, Schien C, Chninou Y, Lindholm L, Winkvist A, Liv P, Stomby A. eHealth versus face-to-face support for remission of type 2 diabetes by calorie restriction (eHealth DIabetes remission Trial): study protocol for a non-inferiority parallel group randomised controlled trial. BMJ Open. 2025 Jul 22;15(7):e095100. doi: 10.1136/bmjopen-2024-095100. PMID 40701606

Идентификаторы

NCT: NCT05491005 · Dnr 2022-02242-01

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗